Ginger (Zingiber officinale) is a widely recognized functional food, known for its anti-inflammatory, antioxidant, and digestive health benefits largely attributed to gingerol-related compounds. While traditional extraction-based methods have been used to characterize these metabolites, they often compromise the spatial context within tissues. This study represents the first application of matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) with ion mobility spectrometry (IMS) to map the detailed spatial distribution of key ginger metabolites (6-, 8-, and 10-gingerols and shogaols) in a complex matrix of an intact rhizome tissue. Rhizomes from five ginger accessions collected in Negros Occidental, Philippines, were cryosectioned at 20 μm, coated with 2,5-dihydroxybenzoic acid (DHB) matrix, and analyzed using MALDI MSI at 100 µm spatial resolution across an m/z range of 50–1200. The MALDI MSI revealed that 6-, 8-, and 10-gingerols were predominantly localized in the stele and cortex regions, while shogaols exhibited broader distribution, including the epidermis. Principal component analysis (PCA) on UPLC-ESI-QTOF-MS data of methanolic rhizome extracts revealed clustering patterns among the five ginger accessions. These findings provide a spatially resolved metabolomic profile of gingerols and shogaols, offering novel insights into the anatomical localization of bioactive compounds. This integrative approach establishes a foundation for future studies on ginger physiology, breeding, and quality control of ginger-derived natural products.
Background: The SARS-CoV-2 3CLpro is essential for viral replication and an attractive target for antiviral intervention. While most strategies target the catalytic site, recent studies suggest that the dimerization interface and cryptic allosteric pockets offer alternative mechanisms for inhibition. Objective: This study investigated lipid metabolites from the marine sediment-derived Streptomyces sp. DSD454T as potential multi-site 3CLpro inhibitors. Methods: Metabolites were extracted from cultured biomass and characterized using LCMS-QTOF, MS/MS (LCMS-TQ), and 1H NMR, with identities confirmed against authentic standards. 3CLpro inhibition was assessed using a FRET-based assay, and ligand–protein interactions were evaluated through molecular docking and MM/GBSA calculations. Lipid content and comparative lipidomic signatures were examined across bioactive Streptomyces strains through LCMS-TQ and BODIPYTM 493/503 staining. Results: Palmitoleic and linoleic acids were identified as major constituents and inhibited SARS-CoV-2 3CLpro with IC50 values of 1.59 µg/mL (6.25 µM) and 5.29 µg/mL (18.88 µM). Molecular docking predicted that both fatty acids bind not only to the catalytic site but also to the dimerization interface and cryptic allosteric pocket. Additional lipids, including 9-heptadecenoic acid, linolenic acid, 9-HODE, and monoacylglycerols such as aggrecerides A–C and glyceryl-based lipids, showed similarly favorable multi-site binding profiles. Streptomyces sp. DSD454T also exhibited substantial lipid accumulation (~63% of crude extract). Across bioactive Streptomyces strains, a conserved lipid signature correlated strongly with 3CLpro inhibition. Conclusions: This study highlights the potential of microbial lipids as promising scaffolds for developing catalytic and allosteric SARS-CoV-2 3CLpro inhibitors and underscore marine Streptomyces as a valuable source of structurally simple yet mechanistically versatile antiviral metabolites.